{"id":724,"date":"2026-09-01T15:21:54","date_gmt":"2026-09-01T15:21:54","guid":{"rendered":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/"},"modified":"2026-09-01T15:32:23","modified_gmt":"2026-09-01T15:32:23","slug":"cjc-1295-dac-randomized-human-pharmacology","status":"publish","type":"case_study","link":"https:\/\/nhdbio.com\/pt-br\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","title":{"rendered":"CJC-1295 com DAC: Farmacologia Humana Randomizada e o Limite de Liga\u00e7\u00e3o \u00e0 Albumina"},"content":{"rendered":"

A quest\u00e3o da identidade vem antes do resultado<\/h2>\n

O composto citado foi projetado como um an\u00e1logo GHRH de a\u00e7\u00e3o prolongada que se liga \u00e0 albumina end\u00f3gena. Essa caracter\u00edstica de design \u00e9 central para a quest\u00e3o farmacocin\u00e9tica. As p\u00e1ginas de pesquisa frequentemente agrupam \u201ccom DAC\u201d e \u201csem DAC\u201d em um \u00fanico nome, mas isso altera a identidade molecular e invalida uma transfer\u00eancia direta da meia-vida relatada.<\/p>\n

O que os testes mediram<\/h2>\n

Os dois ensaios foram randomizados, controlados por placebo, duplo-cegos e com dose crescente. Seus principais resultados foram a exposi\u00e7\u00e3o circulante a GH e IGF-I, al\u00e9m de par\u00e2metros farmacocin\u00e9ticos. Esses s\u00e3o endpoints farmacol\u00f3gicos. N\u00e3o s\u00e3o medidas diretas de melhoria da sa\u00fade, composi\u00e7\u00e3o corporal ou desempenho.<\/p>\n

O curso de tempo relatado<\/h2>\n

Os autores relataram aumentos sustentados e dependentes da dose de GH e IGF-I e uma meia-vida estimada medida em dias. Um estudo complementar relatou que a secre\u00e7\u00e3o puls\u00e1til de GH permaneceu observ\u00e1vel sob est\u00edmulo prolongado. Esses registros suportam uma discuss\u00e3o mecanicista e temporal apenas para o formul\u00e1rio DAC.<\/p>\n

Verifica\u00e7\u00e3o de nome:<\/strong> uma p\u00e1gina que usa o teste cl\u00e1ssico CJC-1295 para descrever \u201cCJC-1295 sem DAC\u201d est\u00e1 misturando dois materiais distintos. A identidade do produto deve corresponder \u00e0 interven\u00e7\u00e3o citada antes de qualquer n\u00famero ser reutilizado.<\/div>\n

O que o estudo n\u00e3o estabelece<\/h2>\n

Dados curtos sobre horm\u00f4nios e exposi\u00e7\u00e3o na fase inicial n\u00e3o estabelecem a efic\u00e1cia terap\u00eautica, a seguran\u00e7a a longo prazo ou a qualidade de um lote comercial. Um lote atual requer identidade pr\u00f3pria, ensaio e documenta\u00e7\u00e3o de libera\u00e7\u00e3o; a literatura n\u00e3o pode substituir esses controles.<\/p>","protected":false},"excerpt":{"rendered":"

Uma leitura atenta dos dois estudos randomizados de dose ascendente em adultos saud\u00e1veis, com foco nos cursos de tempo de GH e IGF-I, meia-vida estimada e por que os resultados n\u00e3o se aplicam a CJC-1295 sem DAC.<\/p>","protected":false},"author":0,"featured_media":852,"template":"","class_list":["post-724","case_study","type-case_study","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nCJC-1295 DAC Human Trial: GH, IGF-I and Half-Life<\/title>\n<meta name=\"description\" content=\"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/pt-br\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary\" \/>\n<meta property=\"og:description\" content=\"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/pt-br\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T15:32:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/\",\"name\":\"CJC-1295 DAC Human Trial: GH, IGF-I and Half-Life\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cjc-1295-dac-editorial-v2.webp\",\"datePublished\":\"2026-09-01T15:21:54+00:00\",\"dateModified\":\"2026-09-01T15:32:23+00:00\",\"description\":\"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cjc-1295-dac-editorial-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cjc-1295-dac-editorial-v2.webp\",\"width\":1672,\"height\":941,\"caption\":\"Editorial laboratory illustration; not an image of a supplied lot or a reported analytical result.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u6848\u4f8b\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CJC-1295 DAC Teste em humanos: GH, IGF-I e Half-Life","description":"Uma leitura atenta dos dois estudos randomizados de dose ascendente em adultos saud\u00e1veis, com foco nos cursos de tempo de GH e IGF-I, meia-vida estimada e por que os resultados n\u00e3o se aplicam a CJC-1295 sem DAC.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/pt-br\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","og_locale":"pt_BR","og_type":"article","og_title":"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary","og_description":"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.","og_url":"https:\/\/nhdbio.com\/pt-br\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","og_site_name":"NHD","article_modified_time":"2026-09-01T15:32:23+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","url":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","name":"CJC-1295 DAC Teste em humanos: GH, IGF-I e Half-Life","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","datePublished":"2026-09-01T15:21:54+00:00","dateModified":"2026-09-01T15:32:23+00:00","description":"Uma leitura atenta dos dois estudos randomizados de dose ascendente em adultos saud\u00e1veis, com foco nos cursos de tempo de GH e IGF-I, meia-vida estimada e por que os resultados n\u00e3o se aplicam a CJC-1295 sem DAC.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","width":1672,"height":941,"caption":"Editorial laboratory illustration; not an image of a supplied lot or a reported analytical result."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"\u6848\u4f8b","item":"https:\/\/nhdbio.com\/case-studies\/"},{"@type":"ListItem","position":3,"name":"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mat\u00e9rias-primas pept\u00eddicas e s\u00edntese personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/case_study\/724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/types\/case_study"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/case_study\/724\/revisions"}],"predecessor-version":[{"id":729,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/case_study\/724\/revisions\/729"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media\/852"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media?parent=724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}